Foundations Investment Advisors, LLC Biomarin Pharmaceutical Inc Transaction History
Foundations Investment Advisors, LLC
- $6.26 Billion
- Q3 2025
A detailed history of Foundations Investment Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Foundations Investment Advisors, LLC holds 3,901 shares of BMRN stock, worth $214,281. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,901
Previous 3,903
0.05%
Holding current value
$214,281
Previous $214,000
1.4%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BMRN
# of Institutions
688Shares Held
187MCall Options Held
1.3MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.25 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$837 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$830 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$675 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...